Journey Medical Earnings Estimate
| DERM Stock | USD 8.35 0.07 0.83% |
Journey Medical Revenue Breakdown by Earning Segment
By analyzing Journey Medical's earnings estimates, investors can diagnose different trends across Journey Medical's analyst sentiment over time as well as compare current estimates against different timeframes. As of the 7th of February 2026, Gross Profit Margin is likely to grow to 0.74, while Gross Profit is likely to drop about 29.9 M. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
Journey Medical Earnings Estimation Breakdown
The calculation of Journey Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Journey Medical is estimated to be 0.063125 with the future projection ranging from a low of 0.0425 to a high of 0.09. Please be aware that this consensus of annual earnings estimates for Journey Medical Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.04 Lowest | Expected EPS | 0.09 Highest |
Journey Medical Earnings Projection Consensus
Suppose the current estimates of Journey Medical's value are higher than the current market price of the Journey Medical stock. In this case, investors may conclude that Journey Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Journey Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 4 | 55.39% | 0.0 | 0.063125 | -0.35 |
Journey Medical Earnings History
Earnings estimate consensus by Journey Medical Corp analysts from Wall Street is used by the market to judge Journey Medical's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only Journey Medical's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Journey Medical Quarterly Gross Profit |
|
Journey Medical Earnings per Share Projection vs Actual
Actual Earning per Share of Journey Medical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Journey Medical Corp predict the company's earnings will be in the future. The higher the earnings per share of Journey Medical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Journey Medical Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Journey Medical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Journey Medical should always be considered in relation to other companies to make a more educated investment decision.Journey Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Journey Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-11-12 | 2025-09-30 | -0.03 | -0.09 | -0.06 | 200 | ||
2025-08-12 | 2025-06-30 | -0.11 | -0.16 | -0.05 | 45 | ||
2025-06-25 | 2025-03-31 | -0.2375 | -0.18 | 0.0575 | 24 | ||
2025-03-26 | 2024-12-31 | -0.1725 | 0.1 | 0.2725 | 157 | ||
2024-11-12 | 2024-09-30 | -0.17 | -0.12 | 0.05 | 29 | ||
2024-08-06 | 2024-06-30 | -0.15 | -0.17 | -0.02 | 13 | ||
2024-05-13 | 2024-03-31 | -0.23 | -0.53 | -0.3 | 130 | ||
2024-03-21 | 2023-12-31 | -0.08 | -0.12 | -0.04 | 50 | ||
2023-11-07 | 2023-09-30 | -0.15 | 0.8 | 0.95 | 633 | ||
2023-08-08 | 2023-06-30 | -0.33 | -0.29 | 0.04 | 12 | ||
2023-05-22 | 2023-03-31 | -0.45 | -0.57 | -0.12 | 26 | ||
2023-03-29 | 2022-12-31 | -0.47 | -0.6 | -0.13 | 27 | ||
2022-11-10 | 2022-09-30 | -0.4 | -0.57 | -0.17 | 42 | ||
2022-08-09 | 2022-06-30 | -0.26 | -0.43 | -0.17 | 65 | ||
2022-05-10 | 2022-03-31 | -0.31 | -0.08 | 0.23 | 74 | ||
2022-03-23 | 2021-12-31 | -0.41 | -1.64 | -1.23 | 300 | ||
2021-12-10 | 2021-09-30 | -0.87 | 0.32 | 1.19 | 136 | ||
2021-09-01 | 2021-06-30 | -1.3 | -0.72 | 0.58 | 44 | ||
2019-11-05 | 2019-09-30 | -1.3 | -1.06 | 0.24 | 18 | ||
2019-08-07 | 2019-06-30 | -0.95 | -0.33 | 0.62 | 65 | ||
2019-05-07 | 2019-03-31 | -1.62 | -1.49 | 0.13 | 8 | ||
2019-02-26 | 2018-12-31 | -1.91 | -1.7 | 0.21 | 10 | ||
2018-11-07 | 2018-09-30 | -1.63 | -1.58 | 0.05 | 3 | ||
2018-08-06 | 2018-06-30 | -0.51 | -0.57 | -0.06 | 11 | ||
2018-05-03 | 2018-03-31 | -1.36 | -1.42 | -0.06 | 4 | ||
2018-02-22 | 2017-12-31 | -1.22 | -1.34 | -0.12 | 9 | ||
2017-11-06 | 2017-09-30 | -1.12 | -4.3 | -3.18 | 283 | ||
2017-08-07 | 2017-06-30 | -0.89 | -0.93 | -0.04 | 4 | ||
2017-05-08 | 2017-03-31 | -0.89 | -0.79 | 0.1 | 11 | ||
2017-02-28 | 2016-12-31 | -0.8 | -0.21 | 0.59 | 73 | ||
2016-11-07 | 2016-09-30 | -0.72 | -0.72 | 0.0 | 0 | ||
2016-08-08 | 2016-06-30 | -0.86 | -0.89 | -0.03 | 3 | ||
2016-05-10 | 2016-03-31 | -0.94 | -0.95 | -0.01 | 1 | ||
2016-03-03 | 2015-12-31 | -0.95 | -1.04 | -0.09 | 9 | ||
2015-11-10 | 2015-09-30 | -0.77 | -0.58 | 0.19 | 24 | ||
2015-08-13 | 2015-06-30 | -0.75 | -0.69 | 0.06 | 8 | ||
2015-05-12 | 2015-03-31 | -0.65 | -0.57 | 0.08 | 12 | ||
2015-03-25 | 2014-12-31 | -0.6 | -0.29 | 0.31 | 51 | ||
2014-11-12 | 2014-09-30 | -0.93 | -8.67 | -7.74 | 832 |
About Journey Medical Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Journey Medical earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Journey Medical estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Journey Medical fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -100.1 M | -105.1 M | |
| Earnings Yield | (0.21) | (0.22) | |
| Price Earnings Ratio | (4.90) | (4.66) | |
| Price Earnings To Growth Ratio | (0.02) | (0.02) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Will Biotechnology sector continue expanding? Could Journey diversify its offerings? Factors like these will boost the valuation of Journey Medical. Projected growth potential of Journey fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Journey Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.35) | Revenue Per Share | Quarterly Revenue Growth 0.205 | Return On Assets | Return On Equity |
Understanding Journey Medical Corp requires distinguishing between market price and book value, where the latter reflects Journey's accounting equity. The concept of intrinsic value - what Journey Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Journey Medical's price substantially above or below its fundamental value.
It's important to distinguish between Journey Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Journey Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Journey Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.